Pittsburgh, Pennsylvania - Bayer Material Science AG has completed work on a new Euro 2.3-million production line for its Baycusan range of waterborne polyurethane dispersions (PUD) for the cosmetics and medical industries, the company said 2 June.
The new facility, part of the PUD plant at the Dormagen Chempark, will produce special polyurethane dispersions of maximum purity that do not contain any kind of co-solvent and are free of preservatives, Bayer said.
"With the start-up of production, we have passed another important milestone," said Joachim Wolff, head of Coatings, Adhesives, Specialities (CAS) at Bayer. "For us, innovation and investment are key to sustainable growth. This project, which we completed in less than two years, is a wonderful example of our innovation strategy," he added.
Wolff said that BMS will invest around 30 percent more in research projects and customer-related developments than in 2007.
The new facility has been designed to be completely germ-free and, thanks to a special process developed by Bayer MaterialScience, the production process dispenses with co-solvents such as NMP (N-methylpyrrolidone) and ethanol, the company said.
Bayer also said that the PU dispersions are suitable for medical applications and the company is preparing to launch a Baycusan product line in the medical market. (RD)